Mark is a radiation protection advisor in radiotherapy based at the Christie, advising on the design and operational safety of the Christie proton centre, and was a co-author of the proton therapy chapter of IPEM report 75: Design and Shielding of Radiotherapy Treatment Techniques. He is currently working on radiation protection for FLASH proton therapy.

Adam S. Harrington, M.S., is the manager for the FLASH Product Management group tasked with developing FLASH for research and clinical use. The team is focused on the development of comprehensive FLASH solutions for both proton and electron FLASH, including delivery, dosimetry, quality assurance, and treatment planning. Recent work from the team resulted in the development and deployment of ProBeam investigational device for the FAST 01 clinical trial and FLASH transmission planning for proton beam therapy. Outside of FLASH, Adam’s professional interest and experience have focused on radiosurgery and motion management, and include the development of HyperArc®, the EDGE® Radiosurgery platform, and the integration of motion monitoring technologies into routine clinical use.